Drug naming pros applaud new virus variant monikers To view this email as a web page,
click here | | Webinar: Accelerating NASH Clinical Trials Tuesday, June 15 | 10am ET / 7am PT Join industry leaders for a webinar dedicated to overcoming key challenges presented in NASH drug development. We’ll explore key considerations for liver biopsy collection and interpretation, emerging non-invasive biomarkers, and the connection between clinical practice and drug development. Register now. |
On a roll, Moderna taps Thermo Fisher for fill-finish duties and Lonza for booster shot manufacturing NRx hopes 'guided missile' COVID-19 antiviral will get FDA clearance on 2nd attempt Samsung adds mRNA vaccine substance capacity, eying a one-stop site to make Moderna's COVID-19 shot Pharma drug naming experts applaud WHO's choice of Greek alphabet for COVID-19 variants COVID-19 tracker: U.K. negotiates with AZ for 'beta' variant shots; Israel finds probable link between Pfizer vaccine, myocarditis Cleveland Clinic posts $61M profit in Q1 thanks to strong patient service revenue Featured Story | By Noah Higgins-Dunn Moderna has tasked Thermo Fisher Scientific with fill-finish, labeling and packaging duties for its mRNA COVID-19 vaccine at Thermo Fisher’s commercial manufacturing site in Greenville, North Carolina. Meanwhile, Swiss CDMO Lonza will also build a new line at a site in the Netherlands to help produce booster shots. read more |
| |
|---|
|
Top Stories By Kyle LaHucik The FDA told NRx Pharmaceuticals to try again in September when they attempted to obtain authorization for a COVID-19 therapy. Now, the biotech thinks they have the data they need to finally get the nod. Radnor, Pennsylvania-based NRx filed for emergency use authorization yesterday with the FDA for aviptadil-acetate, or Zyesami, to be used in COVID-19 patients with respiratory failure. read more By Kevin Dunleavy South Korea CDMO Samsung Biologics said it will add mRNA vaccine substance manufacturing capability, allowing it to fully produce COVID-19 shots. Samsung already had a fill-finish agreement in place to produce Moderna's vaccine. read more By Beth Snyder Bulik What’s in a COVID-19 variant name? Thanks to the World Health Organization, Greek letters. The global health organization's newly announced naming system uses the Greek alphabet in a standardized convention pharma drug naming experts agreed makes sense. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner AstraZeneca is in talks with the British government to supply vaccine doses tailored to the "beta" variant of the coronavirus first identified in South Africa. Officials in Israel said there was a probable link between Pfizer's shot and rare cases of myocarditis. And more headlines. read more By Robert King Cleveland Clinic posted a $61 million profit in the first quarter thanks to strong patient service revenue, but still expects to face cost pressures this year due to COVID-19. read more |
|
